AustinPx
PrivateLast Round
Series C
Oct 16, 2020
Total Funding Raised
$53.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AustinPx is a pharmaceutical services company that provides contract development and manufacturing organization (CDMO) services, specializing in bioavailability enhancement and oral dosage form development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AustinPx Comparables
Compare AustinPx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascendia | 88% | |
| Ascendia Pharmaceutical Solutions | 88% | |
| Serán Bioscience | 85% |
AustinPx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 16, 2020 | ||||
| Early Funding | Apr 26, 2018 | ||||
| Early Funding | Nov 9, 2016 | ||||
| Early Funding | Feb 3, 2015 |
Key People
Founding team and executive leadership
AustinPx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 253% MoM, reaching 7K.
- Apr 26, 2018
$27M raised, led by Research Corporation Technologies.
Recent news
Latest coverage and updates
- recognized_asSep 16, 2026
AustinPx, LLC. recognized as FDA Advanced Manufacturing Technology designation on Sep 16th '26.
- partners_withJun 30, 2026
AustinPx, LLC. partnered with Thermo Fisher Scientific on Jun 30th '26.
AustinPx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AustinPx's valuation, stock price, and market status.
Is AustinPx a public or private company?
AustinPx is a private company.
What is the current stock price of AustinPx?
AustinPx is a private company with no public stock price. No recent secondary market data is available.
How much is AustinPx worth (valuation)?
Valuation information for AustinPx is not publicly available.
Can I buy AustinPx stock?
AustinPx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AustinPx's last funding round?
AustinPx's most recent funding round was Series C on October 16, 2020.
Who are the main investors in AustinPx?
Key investors in AustinPx include Research Corporation Technologies.
Will AustinPx IPO soon?
No public IPO plans have been announced for AustinPx.
How can I track AustinPx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AustinPx's secondary market activity and sign up for updates.